Cigna-Express Scripts nears finish line with approvals from California and New York

Business executives shaking hands
Cigna and Express Scripts are waiting on the nod from New Jersey to close their $67 billion deal by the end of the year. (Getty/Martin Barraud)

Cigna's $67 billion acquisition of Express Scripts cleared regulatory hurdles in two states on Thursday, putting the deal on pace to close by the end of the year.

The megamerger got critical approvals from California and New York and is now waiting for a final approval from New Jersey. The Department of Justice cleared the deal in September.

California Department of Managed Health Care Director Shelley Rouillard approved the megamerger on Thursday with $60 million in concessions from the companies, including a $35 million investment in Cigna’s Collaborative Accountable Care and Delivery System Alliances. Another $10 million will go toward increasing the number of healthcare providers in underserved areas of the state.

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

Cigna and Express Scripts also agreed not to increase premiums as a result of acquisition costs and to keep premium rate increases to a minimum.

RELATED: With merger vote approaching, Cigna and Express Scripts diverge on value-based contracts

“The Department holds each proposed merger to a high standard of review to ensure consumers’ healthcare rights are upheld and access to appropriate healthcare services continues,” Rouillard said in a statement. “The conditions imposed on Cigna and Express Scripts will improve plan performance, increase access to healthcare services and assist in controlling healthcare costs.”

The New York Department of Financial Services determined that a previously scheduled hearing was not required given the "substantial commitments" from the companies. Those included a promise not to raise premiums in New York to pay off more than $24 billion in new debt and an agreement that Cigna will not receive preferential pricing from Express Scripts.

The companies also agreed not to oppose the department's proposed legislation to license and regulate PBMs.

In a financial filing issued after the markets closed on Thursday, Cigna said it continues to work with regulators in New Jersey, the one remaining state where approval is required. The company expects the deal will close by the end of 2018.

Suggested Articles

Civica Rx, the non-profit drug company formed by a collection of hospitals to help control generic drug supplies and prices, is putting down roots.

ONC is moving another step closer to implementing a framework designed to improve data sharing between health information networks.

Welcome news to many health IT stakeholders: HHS announced Friday that it is extending the comment period for two proposed interoperability rules.